ITEM
6. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION
This
report contains forward looking statements within the meaning of section 27a of the securities act of 1933, as amended and section
21e of the securities exchange act of 1934, as amended. The Company's actual results could differ materially from those set forth
on the forward-looking statements as a result of the risks set forth in the company's filings with the Securities and Exchange
Commission, general economic conditions, and changes in the assumptions used in making such forward looking statements.
On
January 5, 2005, the Registrant changed its name to Healthcare Business Services Groups, Inc. The Registrant is a holding company
for subsidiary “Healthcare”. The business operations discussed herein are conducted by “Healthcare”. The
Registrant, through “Healthcare”, is engaged in the business of providing medical billing services to healthcare providers
in the United States.
The
Registrant continued with several Clients billing and sales of AutoMed Software during 2008 and and development of AutoMed software
with two employees and several consultants until December of 2009 and then the Company expanded to as many as 20 employees and
3 to 4 consultants according to need.
On
February 14, 2008, the Registrant changed its name to PPJ Enterprise (the Company) to clear confusion between the Delaware Company
and the Nevada Company. On the same day the Company increased its authorized shares to 1,500,000,000.
On
March 21, 2008 PPJE requested change of Ticker Symbol and it is now (PPJE.PK).
RESULTS
OF OPERATIONS
The
Company is amending 2009 Results of Operations
AMENDED
STATEMENTS BELOW: 2007
Healthcare
Business Services Groups, Inc. (Delaware Corporation a subsidiary of the Nevada Company) moved its office from 1120 W Foothill
Blvd Suite 105 and 106 Upland, CA 91786 and moved to 818 N Mountain Ave, Suite 200, Upland, CA 91786 which was approximately 2600
sqft prestigious space with one year lease. The company kept approximately 11 employees and 5 consultants until end of Oct 2007
and then reduced employees down to 5 and 3 consultants and continued its operation until the Company discovered that its former
Client Dr. Narinder S. Grewal (Grewal) was scamming the Company out of millions of dollars of its assets. Due to Grewal’s
scam, the Company suffered in excess of estimated $100,000,000 million of dollars of loss during the years of 2001 to 2013. Assets
discovered are listed in Exhibit-B which adds up to more than $3,204,919.14 million dollars, having this information and the evidence
in possession the Company brought a lawsuit against Dr Narinder S. Grewal residence of Chatsworth, California practicing in of
Santa Clarita California, Lancaster and his companies such as Santa Clarita Surgery Center for Advance Pain Management and Narinder
S Grewal, MD, Inc. on December 3, 2009 in Los Angeles Superior Court, Los Angeles, California, Case NO. LA BC 427192. Trial on
this Case is currently set for October 30, 2013. In addition, Dr. Grewal breached the agreement for “Medical Billing Agreement”
with the Company in all terms including Non-Compete clause and stole the Company’s proprietary billing methods and started
a billing company naming “G3 Healthcare Business Services, Inc.” which is almost identical name of the company’s
prior subsidiary billing company and became a pain management billing provider and competed with the business of the Company.
Narinder S. Grewal and his wife Pritpal Grewal practically stole the Company’s identity and become the mirror image of the
Registrant’s business. Grewal operates his billing service in Lancaster, California. The Company is also suing Dr. Grewal
and his companies for breach of agreement for Non-Compete. The Company located 2085 patients of Dr. Grewal were missing from the
exclusive billing service agreement during the year of 2004 to 2007. The Company was deprived of more than $4,000,000 to $7,000,000
in revenue in addition to $3,204,919.14 he scammed the Company. The Company is working to confirm the amount of loss based on
evidence. During the year of 2004 and 2007, Grewal was also a member of the Board of Directors of the Company, while he was a
fiduciary of the Company and scamming the Company of its assets, the Company is considering filing a Criminal Investigation with
the U.S. Security and Exchange Commissions against Grewal.
Due
to the negligence of CPA Mr. Ankit Jain of Lake Forest, California 2007 yearly financial only contains the half year of 2007of
the actual operational activities. Mr. Jain failed to perform his duties to complete the second half of the Company’s bank
statements to prepare an accurate financial for which he was paid for.
The
company was aware of overpayments to Narinder S. Grewal and his companies (Grewal) for approximately $706,000 as of 2005 and continued
to work with Grewal to recover this money. But the Company had no knowledge of the findings in 2009 that Grewal has been scamming
the Company of approximately $3.204,919.14 since year 2000. In 2007 auditors were informed of the overpayments but they ignored
to publish because the financials based on cash basis not accrual and due to no signed confirmation from Dr. Grewal at that time.
It was disputed by the company, but the Company was unaware of the true facts of how the overpayments happened.
During
a court trial between Ms. Chandana Basu and Dr. Grewal in 2009 where Dr. Grewal claimed that the company did not pay all money
due him and sued Ms. Basu for $3,000,000. At that time Ms. Basu provided the court with 7 years of accounting review that revealed
Dr. Grewal was paid in excess of $3,204,919.14 over and above due Grewal. Ms. Basu won the trial in that case, but Judge ruled
that the Company must sue Grewal to recover the money. Later that year by a detail analysis with original books and records, the
company came to conclude that Grewal received $3,204,919.14 by scam and other various fraudulent actions.
In
addition the company also discovered that during the exclusive service terms, by breaching Non-Compete clause Grewal was billing
directly using different Tax-Ids and using the company proprietary billing formulas to gain in excess of $50,000,000 to $60,000,000
dollars from his practice to avoid paying fees to the Company of approximately 4,000,000.00 to 7,000,000,000 (estimated).
2007
Revenue was $1,508,452.83 out of which uncollected $826,732 (fees from Grewal) and 2007 Assets amount was $3,204,919.14(actual
amount scammed).
Once
the trial in this case is awarded, the company will amend 10KSB financials of 2007.
Revenues
earned for the years ended December 31, 2009 and 2008 - were $ with the proper amount after discovery made of accounting errors.
Information
below are not accurate as per new discovery of errors in accounting and not to be relied upon due to the negligence of CPA Ankit
Jain. Amended Statements.
The
Company computed the beneficial conversion liability of $1,300,000 and warrant liability of $ 105,762 based on Black-Scholes model.
These amounts have been reflected on the financials as derivative liability in amount of $1,460,962. 2009 and 2008
LIQUIDITY
AND CAPITAL RESOURCES (Subsidiary “Healthcare”) It has been discovered that information below are not reliable due
to the errors in accounting. Amended statements.
Pursuant
to the Securities Purchase Agreement, the Investors purchased the Notes and Warrants in three trenches as set forth below:
At
closing, on July 1, 2006 ("Closing"), the Investors purchased Notes aggregating $700,000 and warrants to purchase 43,750
shares based on the prorate shares of our common stock;
On
August 8, 2006 the investors purchased Notes aggregating $600,000 and warrants to purchase 37,500 shares based on the prorate
shares of our common stock.
Upon
effectiveness of the Registration Statement, the Investors will purchase Notes aggregating $700,000. The Company never received
the third trench as the Registration Statement was not effective to bring more funds into the Company.
The
Notes carry an interest rate of 6% and a maturity date of June 27, 2009. The notes are convertible into common shares at the Applicable
Percentage of the average of the lowest three
(3)
trading prices for our shares of common stock during the twenty (20) trading day period prior to conversion. The "Applicable
Percentage" means 50%; provided, however, that the Applicable Percentage shall be increased to (i) 55% in the event that
a Registration Statement is filed within thirty days of the closing and (ii) 60% in the event that the Registration Statement
becomes effective within one hundred and twenty days from the Closing.
The
Company has an option to prepay the Notes in the event that no event of default exists, there are a sufficient number of shares
available for conversion of the Notes and the market price is at or below $.05 per share. In addition, in the event that the average
daily price of the common stock, as reported by the reporting service, for each day of the month ending on any determination date
is below $.05, the Company may prepay a portion of the outstanding principal amount of the Notes equal to 101% of the principal
amount hereof divided by thirty-six (36) plus one month's interest. Exercise of this option will stay all conversions for the
following month. The full principal amount of the Notes is due upon default under the terms of Notes. In addition, the Company
has granted the investors a security interest in substantially all of its assets and intellectual property as well as registration
rights.
The
Company simultaneously issued to the Investors seven-year warrants to purchase 81,250 shares of common stock at an exercise price
of $28.00.
The
Investors have contractually agreed to restrict their ability to convert the Notes and exercise the Warrants and receive shares
of the Company's common stock such that the number of shares of the Company's common stock held by them and their affiliates after
such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of the Company's common stock.
RISK
FACTORS Due to accounting error the information below is not reliable - Amended statement.
WE
NEED A SUBSTANTIAL AMOUNT OF ADDITIONAL FINANCING.
The
Company anticipates the need for approximately $2,200,000 million dollars of financing for marketing its products and other operational
expenses and growth. There is no assurance that additional financing will be available on favorable terms, if at all. If the Company
is unable to raise such additional financing, or accepts financing on unfavorable terms to the Company, it could have a materially
adverse effect upon the Company's ability to implement its business plan with respect to AutoMed, and other products.
WE
WERE NOT ABLE TO PAY MS. BASU HER CONTRACTED PAY DUE TO LACK OF CASH FLOW BUT HAVE ACCRUED AMOUNT DUE HER FOR HER HANDLING MULTIPLE
JOBS.
Our
original employment agreement with Chandana Basu, our Chief Executive Officer and Treasurer was executed on April 1, 2004 and
cannot be terminated by us. It shall remain in existence until Ms. Basu retires or assigns her position to others. It provides
for a monthly base salary of $5,000 per month and a bonus of 25% of our gross receipts payable monthly with a minimum bonus of
$45,000 per month. It also includes reimbursement of all reasonable expenses. It provides for the issuance of a minimum of 1,000,000
shares annually as per amendment of employment agreement in October 2004.
The
Company was never able to pay Ms. Basu such an amount as agreed in her employment agreement. So Ms. Basu amended her employment
agreement due to Company’s financial conditions during the First Quarter of 2008 as below:
Ms.
Basu will accept $5,000 as salary and $20,000 worth of Company’s Common Shares per month for the first six months. After
six months her salary must increase $1,000 per month to a maximum $10,000 per month and $20,000 worth of Company’s S-8 shares
per month and then the agreement would revert back to original agreement.
On
April 29, 2008 Ms. Basu accepted $937,665 Officers Due liability in Company Common and Preferred Socks of the Company as a full
payment towards all accrued dues including bonuses as of 12/31/2007. Amended Statements
Ms.
Basu also serves as the Chief Executive Officer and President of AutoMed. Ms. Basu is our only employee at this time. She travels
for marketing, deals with the auditors, attorneys, and investors in addition she works closely with programmers and other technical
professionals to continuously improve the status of the Company.
WE
MAY NOT BE ABLE TO DEVELOP A MARKET FOR AUTOMED IN THE EVENT THAT WE ARE ABLE TO RAISE ENOUGH MONEY TO MARKET AUTOMED.
The
Company completed development of the basic version of AutoMed software as a stand-alone, commercially viable product, the Company
plans to market AutoMed as a "one-stop shopping" solution for medical office management. The Company plans to charge
$50,000 per installation for a single user and one computer. Currently the Company generates some revenue through AutoMed. The
extent to which AutoMed gains acceptance, if any, will depend, in part, on its cost effectiveness and performance as compared
to conventional means of office management, as well as known or unknown alternative software packages. If conventional means of
office management or alternative software packages are more costeffective or outperform AutoMed, the demand for AutoMed may be
adversely affected. Additionally, the Company anticipates the need for approximately $2,200,000 Million dollars to begin marketing
AutoMed. The failure of the Company to raise an additional $2,200,000 to implement our Business Plan and maintain levels of market
acceptance would have a material adverse effect on the line of business and the Company's overall business, financial condition
and results of operations, and would likely cause the value of the Company's securities to decrease.
OUR
AUDITORS HAVE EXPRESSED AN OPINION THAT THERE IS SUBSTANTIAL DOUBT ABOUT OUR ABILITY TO CONTINUE AS A GOING CONCERN.
As
of December 31, 2009 and 2008 the Company has accumulated deficit amounting to $3,649,491 and $ 2,130,67 2 respectively, net loss
amounting $ 133,873 and 185,353 and net cash used in operations of $27,771 and $103,353. The accompanying financial statements
have been prepared assuming that the Company will continue as a going concern. The financial statements do not include any adjustments
that might result from our inability to continue as a going concern. Our continuation as a going concern is dependent upon future
events, including obtaining financing (discussed above) for expansion and to implement our business plan with respect to AutoMed,
if we are unable to continue you will lose your investment.
WE
RELY ON KEY MANAGEMENT.
The
success of the Company depends upon the personal efforts and abilities of Chandana Basu. The Company faces competition in retaining
Ms. Basu and in attracting new personnel should Ms. Basu choose to leave the Company. There is no assurance that the Company will
be able to retain and/or continue to adequately motivate Ms. Basu in the future. The loss of Ms. Basu or the Company's inability
to continue to adequately motivate her could have a material adverse effect on the Company's business and operations.
BECAUSE
MS. CHANDANA BASU OWNS 81.1% OF OUR OUTSTANDING COMMON STOCK, SHE WILL EXERCISE CONTROL OVER CORPORATE DECISIONS THAT MAY BE ADVERSE
TO OTHER MINORITY SHAREHOLDERS.
Chandana
Basu, a Director of the Company and the Company's Chief Executive Officer and Treasurer, owns approximately 81.1% of the issued
and outstanding shares of our common stock. Accordingly, she will exercise control in determining the outcome of all corporate
transactions or other matters, including mergers, consolidations and the sale of all or substantially all of our assets, and also
the power to prevent or cause a change in control. The interests of Ms. Basu may differ from the interests of the other stockholders
and thus result in corporate decisions that are adverse to other shareholders.
IF
THERE'S A MARKET FOR OUR COMMON STOCK
,
OUR STOCK PRICE MAY BE VOLATILE.
If
there's a market for our common stock, we anticipate that such market would be subject to wide fluctuations in response to several
factors, including, but not limited to:
|
•
|
actual
or anticipated variations in our results of operations;
|
|
•
|
our
ability or inability to generate new revenues;
|
|
•
|
increased
competition; and
|
|
•
|
conditions
and trends in the medical billing industry.
|
Further,
because our common stock is trading on the Pink sheets our stock price may be impacted by factors that are unrelated or disproportionate
to our operating performance. These market fluctuations, as well as general economic, political and market conditions, such as
recessions, interest rates or international currency fluctuations may adversely affect the market price of our common stock.
CRITICAL
ACCOUNTING POLICIES
Our
discussion and analysis of our financial condition and results of operations is based upon our financial statements, which have
been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial
statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses,
and related disclosure of any contingent assets and liabilities. On an on-going basis, we evaluate our estimates. We base our
estimates on various assumptions that we believe to be reasonable under the circumstances, the results of which form the basis
for making judgments about carrying values of assets and liabilities that are not readily apparent from other sources. Actual
results may differ from these estimates under different assumptions or conditions.
ITEM
7. FINANCIAL STATEMENTS TO BE AMENDED
Consolidated
Balance Sheets
(Unaudited)
|
|
December
31,
|
|
|
2009
|
|
2008
|
|
2007
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
11,024
|
|
|
$
|
5,890
|
|
|
$
|
4,200
|
|
Software Development
Costs
|
|
|
17,050
|
|
|
|
43,000
|
|
|
|
127,000
|
|
Inventory
|
|
|
55,000
|
|
|
|
50,000
|
|
|
|
25,700
|
|
Accounts Receivable
|
|
|
383,770
|
|
|
|
165,000
|
|
|
|
7,989,010
|
|
Fixed Assets
|
|
|
33,000
|
|
|
|
30,000
|
|
|
|
75,000
|
|
Other
Current Assets
|
|
|
4,953,905
|
|
|
|
4,503,550
|
|
|
|
4,326,570
|
|
Total
Assets
|
|
$
|
5,442,725
|
|
|
$
|
4,754,440
|
|
|
$
|
12,547,480
|
|
Liabilities
& Stockholders' (Deficit)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts
Payable and Accrued Expenses
|
|
$
|
1,121,869
|
|
|
$
|
1,086,869
|
|
|
$
|
1,977,851
|
|
Accrued
Officer Compensation
|
|
|
180,000
|
|
|
|
60,000
|
|
|
|
937,665
|
|
Lines of Credit
|
|
|
2,230
|
|
|
|
—
|
|
|
|
100,415
|
|
Derivative
Liability
|
|
|
|
|
|
|
|
|
|
|
|
|
Lease
Liability
|
|
|
2,230
|
|
|
|
—
|
|
|
|
18,938
|
|
Notes
Payable
|
|
|
376,050
|
|
|
|
498,000
|
|
|
|
508,500
|
|
Convertible
Secured Note
|
|
|
1,168,021
|
|
|
|
1,203,546
|
|
|
|
1,460,962
|
|
Total
Current Liabilities
|
|
|
2,848,170
|
|
|
|
3,179,715
|
|
|
|
6,304,331
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Commitments & Contingencies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stockholders' Equity
(Deficit)
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock-Class
B, $0.001 par value, 100,000,000 shares authorized; no shares issued and outstanding.
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Common Stock, $0.001
par value, 1,500,000,000 shares authorized; 428,226 and 85,200 shares issued and outstanding, respectively.
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Additional
Paid-in Capital
|
|
|
801,321
|
|
|
|
6,191
|
|
|
|
2,535,156
|
|
Stock
Subscriptions (Receivable) Payable
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
Deficit
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
Stockholders' (Deficit)
|
|
|
(3,649,491
|
)
|
|
|
(2,130,672
|
)
|
|
|
(8,915,665
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
Liabilities & Stockholders' (Deficit)
|
|
$
|
5,442,725
|
|
|
$
|
4,754,440
|
|
|
$
|
12,547,480
|
|
The
accompanying notes are an integral part of these financial statements.
Consolidated
Statements of Operations
Unaudited
|
|
For
the Twelve Months Ended
December
31,
|
|
|
2009
|
|
2008
|
Income
from Operation
|
|
|
|
|
|
|
|
|
Income
|
|
$
|
152,000
|
|
|
$
|
103,000
|
|
Beneficial
Conversion Feature Expense
|
|
|
|
|
|
|
|
|
Interest
Expense and Financing Costs
|
|
|
(106,102
|
)
|
|
|
-122,278
|
|
Total
Other Income (Expense)
|
|
|
45,898
|
|
|
|
(19,278
|
)
|
|
|
|
|
|
|
|
|
|
Provision for
Income Taxes
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Net
Income (Loss) Before Operations
|
|
|
45,989
|
|
|
|
(19.278
|
)
|
|
|
|
|
|
|
|
|
|
Loss from Operations
|
|
|
(27,771
|
)
|
|
|
(103,353
|
)
|
Loss
from Disposal of Assets of Operations
|
|
|
—
|
|
|
|
—
|
|
Loss
from Operations
|
|
|
—
|
|
|
|
—
|
|
Total Loss from
Operations
|
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Net
Income (Loss)
|
|
$
|
(133,873
|
)
|
|
|
(185,353
|
)
|
|
|
|
|
|
|
|
|
|
Net Income per Share
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
—
|
|
|
|
—
|
|
Diluted
|
|
$
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Number of Shares Used in Per Share Calculations
|
|
|
|
|
|
|
|
|
Basic
|
|
|
—
|
|
|
|
—
|
|
Diluted
|
|
|
—
|
|
|
|
—
|
|
The
accompanying notes are an integral part of these financial statements.
Consolidated
Statements of Stockholders' Equity (Deficit)
Number of Shares
|
Par
Value ($0.001)
Amount
|
Additional
Paid-In-
Capital
|
Prepaid
Consulting
|
Subscriptions
(Receivable)
Payable
|
Accumulated
Deficit
|
Total
Stockholders'
Equity
(Deficit)
|
Consolidated
Statements of Cash Flow
|
For
the Twelve Month Ended December 31,
|
|
2009
|
|
2008
|
Cash
Flows from Operating Activities
|
|
(133,873
|
)
|
|
|
(185,353
|
)
|
Net
Income (Loss)
|
|
(133,873
|
)
|
|
|
(185,353
|
)
|
|
|
|
|
|
|
|
|
Adjustments
to reconcile net loss to net cash used in operating activities:
|
|
|
|
|
|
|
|
Stock
Based Compensation
|
|
|
|
|
|
|
|
Depreciation
& Amortization
|
|
—
|
|
|
|
—
|
|
Beneficial
Conversion Feature Expense
|
|
—
|
|
|
|
—
|
|
Change
in Fair Value of Derivative
|
|
—
|
|
|
|
—
|
|
Loss
from Disposal of Assets of Operations
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
Changes
in operating assets and liabilities:
|
|
—
|
|
|
|
—
|
|
Accounts
Receivable
|
|
—
|
|
|
|
—
|
|
Accounts
Payable and Accrued Expenses
|
|
—
|
|
|
|
—
|
|
Accrued
Officer Compensation
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Net
Cash Used in Operating Activities
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Cash Flows from Investing
Activities
|
|
—
|
|
|
|
—
|
|
Purchase
of Property and Equipment
|
|
—
|
|
|
|
—
|
|
Software
Development Costs
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Net
Cash Used in Investing Activities
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Cash Flows from Financing
Activities
|
|
—
|
|
|
|
—
|
|
Lines of Credit
|
|
—
|
|
|
|
—
|
|
Payments
on Capital Leases
|
|
—
|
|
|
|
—
|
|
Net
Proceeds from Notes Payable
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Net
Cash Provided by Financing Activities
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
Increase (Decrease) in Cash
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Cash Beginning of
Period
|
|
—
|
|
|
|
—
|
|
|
|
|
|
|
|
|
|
Cash
End of Year
|
$
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
—
|
|
Supplemental
Disclosure of Cash Flow Information:
|
|
—
|
|
|
|
—
|
|
Cash
Paid during the period for interest
|
|
—
|
|
|
|
—
|
|
Cash
Paid during the period for income taxes
|
|
—
|
|
|
|
1,700
|
|
The
accompanying notes are an integral part of these financial statements.
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
Note
1 – Organization, Business & Operations
History
The
Company was incorporated in the State of Nevada on May 2, 2000, as Winfield Capital Group, Inc. On June 6, 2001, the Company filed
a Certificate of Amendment to its Articles of Incorporation to affect a name change to "Winfield Financial Group, Inc."
On April 23, 2004, the Company acquired 100% of the equity interest of Healthcare Business Services Groups, Inc. ("Healthcare").
As part of the same transaction, the Company acquired 100% of the equity interest of AutoMed Software Corp. ("AutoMed")
and Silver Shadow Properties, LLC ("Silver Shadow") on May 7, 2004. Prior to the Acquisition (defined below), the Company
was a business broker, primarily representing sellers and offering its clients' businesses for sale. As a result of the acquisition,
the Company changed its business focus to medical billing. On January 7, 2005, the Company filed a Certificate of Amendment to
its Articles of Incorporation, with the Nevada Secretary of State and changed its name to "Healthcare Business Services Groups,
Inc."
On
April 23, 2004, the Company acquired 100% of the issued and outstanding shares of Healthcare Business Services Groups, Inc., a
Delaware corporation ("Healthcare"). As part of the same transaction on May 7, 2004, the Company acquired 100% of the
issued and outstanding shares of AutoMed Software Corp., a Nevada corporation ("AutoMed"), and 100% of the membership
interests of Silver Shadow Properties, LLC, a Nevada single member limited liability company ("Silver Shadow"). The
transactions are collectively referred to herein as the "Acquisition." The Company acquired Healthcare, AutoMed, and
Silver Shadow from Chandana Basu, the sole owner, in exchange for 25,150,000 newly issued treasury shares of the Company's Common
Stock. As a result of the Acquisition, the Company has changed its business focus. The term "Company" shall include
a reference to Healthcare Business Services Groups, Inc. (the "Company").
The
merger of the Company with Healthcare Business Services Groups Inc., has been accounted for as a reverse acquisition under the
purchase method of accounting since the shareholders of Healthcare Business Services Groups Inc. obtained control of the consolidated
entity. Accordingly, the merger of the two companies has been recorded as a recapitalization of the Healthcare Business Services
Groups Inc., with Healthcare Business Services Groups Inc. being treated as the continuing entity. The continuing company has
retained December 31 as its fiscal year end.
AMENDED
STATEMENTS
Healthcare
was a medical billing service provider that for over SEVENTEEN years had assisted various health care providers to successfully
enhance their billing function.
Name
Change
A
Certificate of Amendment to the Articles of Incorporation to change the registrant’s name to PPJ Enterprise which amendment
became effective on March 20, 2008. As a result of the name change, the Company’s trading symbol changed from “HBSV”
to “PPJE”.
An
amendment to the Registrant’s Articles of Incorporation to increase the authorized shares to 1,500,000,000 shares of common
stock, to reauthorize the par value of $.001 per share of common stock, and to authorize additional 95,000,000 shares of preferred
stock making it a total of 100,000,000 with a par value of $.001 per share of preferred stock that became effective March 20,
2008; and 300,000,000 Free Trading shares also were registered with Nevada Secretary of State on March 20, 2008.
On
March 20, 2008, the Board of Directors approved an Amendment for a 1:400 reverse stock split. All references in the financial
statements to the number of shares outstanding, per share amounts, and stock options data of the Company’s common stock
have been restated to reflect the effect of the reverse stock split for all periods presented.
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
Note
2 - Going Concern and Management's Plans
AMENDED
STATEMENT – DUE TO ACCOUNTING ERRORS THE INFORMATION BELOW IS NOT RELIABLE
The
accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles
which contemplate continuation of the company as a going concern. However, as of December 31, 2008, the Company has an accumulated
deficit of $2,130,672 and as of December 31, 2009 the Company has an accumulated deficit of $3,649,49. These and other factors
raise substantial doubt about the Company's ability to continue as a going concern.
The
ability of the Company to continue as a going concern is dependent upon its ability to raise additional capital and achieve profitable
operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company
is unable to continue as a going concern.
Note
3 - Summary of Significant Accounting Policies
Principles
of Consolidation
The
accompanying consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries, AutoMed
Software Corp., and Silver Shadow Properties, LLC. All significant inter-company accounts and transactions have been eliminated
in consolidation. The acquisition of Healthcare Business Services Groups Inc. on May 7, 2004, has been accounted for as a purchase
and treated as a reverse acquisition.
Cash
and Cash Equivalents
The
Company considers all liquid investments with a maturity of three months or less from the date of purchase that are readily convertible
into cash to be cash equivalents.
Inventories
Inventories
are stated at the lower of cost or market. Cost is computed on a weighted-average basis, which approximates the first-in, first-out
method; market is based upon estimated replacement costs. Costs included in inventory primarily include finished spirit product
and packaging.
Use
of Estimates
The
preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual
results could differ from those estimates
Property
& Equipment
Property
and equipment are recorded at cost. Depreciation is computed using the straight-line method over useful lives of 3 to 10 years.
The cost of assets sold or retired and the related amounts of accumulated depreciation are removed from the accounts in the year
of disposal. Any resulting gain or loss is reflected in current operations. Assets held under capital leases are recorded at the
lesser of the present value of the future minimum lease payments or the fair value of the leased property. Expenditures for maintenance
and repairs are charged to operations as incurred.
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
Impairment
of Long-Lived Assets
Effective
January 1, 2002, the Company adopted Statement of Financial Accounting Standards No. 144, "Accounting for the Impairment
or Disposal of Long-Lived Assets" ("SFAS 144"), which addresses financial accounting and reporting for the impairment
or disposal of long-lived assets and supersedes SFAS No. 121, "Accounting for the Impairment of Long-Lived Assets and for
Long-Lived Assets to be Disposed Of," and the accounting and reporting provisions of APB Opinion No. 30, "Reporting
the Results of Operations for a Disposal of a Segment of a Business." The Company periodically evaluates the carrying value
of long-lived assets to be held and used in accordance with SFAS 144. SFAS 144 requires impairment losses to be recorded on long-lived
assets used in operations when indicators of impairment are present and the undiscounted cash flows estimated to be generated
by those assets are less than the assets' carrying amounts. In that event, a loss is recognized based on the amount by which the
carrying amount exceeds the fair market value of the long-lived assets. Loss on long-lived assets to be disposed of is determined
in a similar manner, except that fair market values are reduced for the cost of disposal.
Basic
and Diluted Net Income per Share
Basic
earnings per share is calculated using the weighted-average number of common shares outstanding during the period without consideration
of the dilutive effect of stock warrants and convertible notes. Diluted earnings per share is calculated using the weighted-average
number of common shares outstanding during the period after consideration of the dilutive effect of stock warrants and convertible
notes.
Stock-Based
Compensation
In
December 2004, the Financial Accounting Standards Board (FASB) issued SFAS No. 123(R), Share-Based Payment. This pronouncement
amends SFAS No. 123, Accounting for Stock Based Compensation, and supersedes APB Opinion No. 25, Accounting for Stock Issued to
Employees. SFAS No. 123(R) requires that companies account for awards of equity instruments issued to employees under the fair
value method of accounting and recognize such amounts in their statements of operations. Under SFAS No. 123(R), we are required
to measure compensation cost for all stock-based awards at fair value on the date of grant and recognize compensation expense
in our consolidated statements of operations over the service period that the awards are expected to vest.
The
Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of SFAS
123(R) and the Emerging Issues Task Force consensus in Issue No. 96-18 ("EITF 96-18"), "Accounting for Equity Instruments
that are Issued to Other Than Employees for Acquiring or in Conjunction with Selling, Goods or Services". Common stock issued
to non-employees in exchange for services is accounted for based on the fair value of the services received.
Fair
Value of Financial Instruments
Statement
of financial accounting standard No. 107, Disclosures about Fair Value of Financial Instruments, requires that the Company disclose
estimated fair values of financial instruments. The carrying amounts reported in the statements of financial position for current
assets and current liabilities qualifying as financial instruments are a reasonable estimate of fair value.
Revenue
Recognition
The
Company's revenue recognition policies are in compliance with Staff accounting bulletin SAB 104. All revenue is recognized when
persuasive evidence of an arrangement exists, the service or sale is complete, the price is fixed or determinable and collectability
is reasonably assured. Revenue is derived from collections of medical billing services. Revenue is recognized when the collection
process is complete which occurs when the money is collected and recognized on a net basis.
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
License
Revenue - The Company recognizes revenue from license contracts when a non-cancelable, non-contingent license agreement has been
signed, the software product has been delivered, no uncertainties exist surrounding product acceptance, fees from the agreement
are fixed and determinable and collection is probable. Any revenues from software arrangements with multiple elements are allocated
to each element of the arrangement based on the relative fair values using specific objective evidence as defined in the SOPs.
If no such objective evidence exists, revenues from the arrangements are not recognized until the entire arrangement is completed
and accepted by the customer. Once the amount of the revenue for each element is determined, the Company recognizes revenues as
each element is completed and accepted by the customer. For arrangements that require significant production, modification or
customization of software, the entire arrangement is accounted for by the percentage of completion method, in conformity with
Accounting Research Bulletin ("ARB") No. 45 and SOP 81-1.
Services
Revenue - Revenue from consulting services is recognized as the services are performed for time-and-materials contracts and contract
accounting is utilized for fixed-price contracts. Revenue from training and development services is recognized as the services
are performed. Revenue from maintenance agreements is recognized ratably over the term of the maintenance agreement, which in
most instances is one year.
Allowance
for Doubtful Accounts
We
provide an allowance for estimated uncollectible accounts receivable balances based on historical experience and the aging of
the related accounts receivable.
Advertising
The
Company expenses advertising costs as incurred. The Company incurred no advertising costs for the years ended December 31, 2008
and 2009 data $16,421 and $11,000.
Income
Taxes
The
Company accounts for income taxes using the liability method as required by Statement of Financial Accounting Standards ("FASB")
No. 109, Accounting for Income Taxes ("SFAS 109"). Under this method, deferred tax assets and liabilities are determined
based on differences between their financial reporting and tax basis of assets and liabilities. The Company was not required to
provide for a provision for income taxes for the periods ended December 31, 2009 and 2008, as a result of net operating losses
incurred during the periods. As of December 31, 2009 and 2008, the Company has net operating losses of ($133,873) and ($185.363)
available for income tax purposes that may be carried forward to offset future taxable income, if any. These carryforwards expire
in various years through 2026. At December 31, 2009 and 2008, the Company has deferred tax assets of approximately 0.00 relating
to the Company's net operating losses, respectively. The Company's deferred tax asset has been fully reserved by a valuation allowance
since realization of its benefit is uncertain. The Company's ability to utilize its NOL carryforwards may be subject to an annual
limitation in future periods pursuant to Section 382 of the Internal Revenue Code of 1986, as amended.
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
The
provision for income taxes using the federal and state tax rates as compared to the Company's effective tax rate is summarized
as follows:
|
|
December
31,
|
|
|
|
2007
|
|
|
2006
|
|
|
|
|
|
|
|
|
|
|
Statutory
Federal Tax (Benefit) Rate
|
|
|
-34
|
%
|
|
|
-34
|
%
|
Statutory
State Tax (Benefit) Rate
|
|
|
-6
|
%
|
|
|
-6
|
%
|
Effective
Tax (Benefit) Rate
|
|
|
-40
|
%
|
|
|
-40
|
%
|
|
|
|
|
|
|
|
|
|
Valuation
Allowance
|
|
|
40
|
%
|
|
|
40
|
%
|
|
|
|
|
|
|
|
|
|
Effective
Income Tax
|
|
|
0
|
%
|
|
|
0
|
%
|
Significant
components of the Company's deferred tax assets at December 31, 2008 and 2009, are as follows:
|
|
December
31,
|
|
|
|
2009
|
|
|
2008
|
|
Net
Deferred Tax Asset
|
|
$
|
-
|
|
|
$
|
-
|
|
Research
and Development Costs
Expenditures
for research & development are expensed as incurred. Such costs are required to be expensed until the point that technological
feasibility is established. The Company incurred no research and development costs for the years ended December 31, 2009 and 2008
was $17,050 and $43,000.
Reclassifications
Certain
items in the prior year financial statements have been reclassified for comparative purposes to conform to the presentation in
the current period’s presentation. These reclassifications have no effect on the previously reported income (loss).
Recently
Issued Accounting Pronouncements
In
December 2007, the FASB issued SFAS No. 141(R), Business Combinations (FAS 141(R)). This Statement provides greater consistency
in the accounting and financial reporting of business combinations. It requires the acquiring entity in a business combination
to recognize all assets acquired and liabilities assumed in the transaction, establishes the acquisition date fair value as the
measurement objective for all assets acquired and liabilities assumed, and requires the acquirer to disclose the nature and financial
effect of the business combination. FAS 141(R) is effective for fiscal years beginning after December 15, 2009. We will adopt
FAS 141(R) no later than the first quarter of fiscal 2010 and are currently assessing the impact the adoption will have on our
financial position and results of operations.
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
In
December 2007, the FASB issued SFAS No. 160. Noncontrolling Interests in Consolidated Financial Statements (FAS 160). This Statement
amends Accounting Research Bulletin No. 51, Consolidated Financial Statements, to establish accounting and reporting standards
for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. FAS 160 is effective for fiscal years
beginning after December 15, 2008. We will adopt FAS 160 no later than the first quarter of fiscal 2010 and are currently assessing
the impact the adoption will have on our financial position and results of operations.
In
February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities, which permits
entities to choose to measure at fair value eligible financial instruments and certain other items that are not currently required
to be measured at fair value. This statement requires that unrealized gains and losses on items for which the fair value option
has been elected be reported in earnings at each subsequent reporting date. SFAS No. 159 is effective for fiscal years beginning
after November 15, 2007. We will adopt SFAS No. 159 no later than the first quarter of fiscal 2009. We are currently assessing
the impact the adoption of SFAS No. 159 will have on our financial position and results of operations.
In
September 2006, the FASB issued SFAS No. 158, Employers’ Accounting for Defined Benefit Pension and Other Postretirement
Plans, an amendment of FASB Statements No. 87, 88, 106, and 132(R). SFAS No. 158 requires company plan sponsors to display the
net over or under-funded position of a defined benefit postretirement plan as an asset or liability, with any unrecognized prior
service costs, transition obligations or actuarial gains/losses reported as a component of other comprehensive income in shareholders’
equity. SFAS No. 158 is effective for fiscal years ending after December 15, 2006. We adopted the recognition provisions of SFAS
No. 158 as of the end of fiscal 2007. The adoption of SFAS No. 158 did not have an effect on the Company’s financial position
or results of operations.
In
September 2006, the FASB issued SFAS No. 157, Fair Value Measurements. SFAS No. 157 establishes a framework for measuring fair
value in generally accepted accounting principles, clarifies the definition of fair value and expands disclosures about fair value
measurements. SFAS No. 157 does not require any new fair value measurements. However, the application of SFAS No. 157 may change
current practice for some entities. SFAS No. 157 is effective for financial statements issued for fiscal years beginning after
November 15, 2007, and interim periods within those fiscal years. We will adopt SFAS No. 157 in the first quarter of fiscal 2009.
We are currently assessing the impact that the adoption of SFAS No. 157 will have on our financial position and results of operations.
In
July 2006, the FASB issued Interpretation No. 48, Accounting for Uncertainty in Income Taxes — an interpretation of FASB
Statement No. 109 (FIN 48). This interpretation clarifies the application of SFAS No. 109, Accounting for Income Taxes, by defining
a criterion that an individual tax position must meet for any part of the benefit of that position to be recognized in an enterprise’s
financial statements and also provides guidance on measurement, derecognition, classification, interest and penalties, accounting
in interim periods, disclosure and transition. FIN 48 is effective for fiscal years beginning after December 15, 2006, but earlier
adoption is permitted. The Company is in the process of evaluating the impact of the application of the Interpretation to its
financial statements.
Note
4 – Operations
.
The
accompanying financial statements have been reclassified accordingly and presented as operations. The Company's other three subsidiaries;
Silver Shadow, AutoMed and Alta Vista, are dormant companies and are also reclassified as part of operations.
|
|
For
the Twelve Months Ended
|
|
|
|
December
31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
|
|
|
|
|
Net
Revenue
|
|
$
|
(133,873)
|
|
|
$
|
(185,353)
|
|
Operating
Expenses
|
|
|
156,800
|
|
|
|
226,631
|
|
Loss
from Operations
|
|
|
(133,873
|
)
|
|
|
(185,353
|
)
|
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
Note
5 - Property and Equipment
As
of December 31, 2009 and 2008, property and equipment is comprised of the following:
|
|
December
31,
|
|
|
|
2009
|
|
|
2008
|
|
|
|
|
|
|
|
|
Office
and Computer Equipment
|
|
|
-
|
|
|
|
-
|
|
Furniture
& Equipment
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Less:
Accumulated Depreciation
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Net
Property & Equipment
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
Depreciation
Expense
|
|
$
|
-
|
|
|
$
|
-
|
|
|
|
|
-
|
|
|
|
-
|
|
Note
6 – Software Development Costs
The
Company is accounting for computer software technology costs under the Capitalization criteria of Statement of Position 98-1 "Accounting
for the Costs of Computer Software
Developed
for Internal Use. And for distributions"
Expenditures
for maintenance and repairs are expensed when incurred; additions, renewals and betterments are capitalized. Amortization is computed
using the straight-line method over the estimated useful life of the asset. Amortization begins from the date when the software
becomes operational. The website became operational July 1, 2004. The cost of software development in 2009 and 2008 are $17050
and $43,000 in the accompanying financial statements at December 31, 2009 and 2008, respectively.
Note
7– Accounts Payable and Accrued Expenses
As
of December 31, 2009 and 2008, accounts payable and accrued expenses consist of the following:
Accounts
payable was $1,121,869 and $1086,869 respectively
Accrued
officer’s compensation was $1,177,665 and $997,665 (total accrued)
Total
Accounts Payable and Accrued Expenses $ 1,652,796
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
Note
8 – Accrued Officer Compensation
As
of December 31, 2009 and 2008, accrued officer compensation totaled for the year $60,000 and $120,000, respectively.
Note
9 – Lines of Credit
Note
10 – Notes Payable
Note
11 - Convertible Secured Note and Securities Purchase Agreement
On
June 27, 2006, the Company entered into a Securities Purchase Agreement (the "Securities Purchase Agreement") with New
Millennium Capital Partners II, LLC, AJW Qualified Partners, LLC, AJW Offshore, Ltd. and AJW Partners, LLC (collectively, the
"Investors"). Under the terms of the Securities Purchase Agreement, the Investors purchased an aggregate of (i) $2,000,000
in callable convertible secured notes (the "Notes") and (ii) warrants to purchase 125,000 reverse split shares of our
common stock (the "Warrants").
Pursuant
to the Securities Purchase Agreement, the Investors purchased the Notes and Warrants in three trenches as set forth below:
·
At closing, on July 1, 2006 ("Closing"), the Investors purchased Notes aggregating $700,000 and warrants to purchase
43,750 shares based on the prorate shares of our common stock;
·
On August 8, 2006 the investors purchased Notes aggregating $600,000 and warrants to purchase 37,500 shares based on the prorate
shares of our common stock.
·
Upon effectiveness of the Registration Statement, the Investors will purchase Notes aggregating $700,000. The Company has
withdrawn the third trench as the Registration Statement was not effective to bring more funds into the Company.
The
Notes carry an interest rate of 6% and a maturity date of June 27, 2009. The notes are convertible into common shares at the Applicable
Percentage of the average of the lowest three
(3)
trading prices for our shares of common stock during the twenty (20) trading day period prior to conversion. The "Applicable
Percentage" means 50%; provided, however, that the Applicable Percentage shall be increased to (i) 55% in the event that
a Registration Statement is filed within thirty days of the closing and (ii) 60% in the event that the Registration Statement
becomes effective within one hundred and twenty days from the Closing.
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
The
Company has an option to prepay the Notes in the event that no event of default exists, there are a sufficient number of shares
available for conversion of the Notes and the market price is at or below $.05 per share. In addition, in the event that the average
daily price of the common stock, as reported by the reporting service, for each day of the month ending on any determination date
is below $.05, the Company may prepay a portion of the outstanding principal amount of the Notes equal to 101% of the principal
amount hereof divided by thirty-six (36) plus one month's interest. Exercise of this option will stay all conversions for the
following month. The full principal amount of the Notes is due upon default under the terms of Notes. In addition, the Company
has granted the investors a security interest in substantially all of its assets and intellectual property as well as registration
rights.
The
Company has received the $ 1,300,000 through December 31, 2007.
Note
12 – Derivative Liability
Concurrent
with the issuance of the $1,300,000 note detailed in Note 11, the Company issued to the Investors seven year warrants to purchase
81,250, post reverse split shares, of common stock at an exercise price of $28.00.
The
Investors have contractually agreed to restrict their ability to convert the Notes and exercise the Warrants and receive shares
of the Company's common stock such that the number of shares of the Company's common stock held by them and their affiliates after
such conversion or exercise does not exceed 4.99% of the then issued and outstanding shares of the Company's common stock.
The
fair value of the share purchase warrants for the period December 31, 2007, was in the amount of $1,460,962, which was determined
using the Black-Scholes option value model with the following assumptions:
·
Expected life 5.6 years
·
Volatility 98%
·
Dividend yield 0%
·
Risk free rate 3.5%
Note
13 - Stockholders’ Equity
Authorized
Shares
An
amendment to the Registrant’s Articles of Incorporation to increase the authorized shares to 1,500,000,000 shares of common
stock, to reauthorize the par value of $.001 per share of common stock, and to authorize additional 95,000,000 shares of preferred
stock making it a total of 100,000,000 with a par value of $.001 per share of preferred stock that became effective March 20,
2008; and 300,000,000 Free Trading shares also were registered with Nevada Secretary of State on March 20, 2008.
Reverse
Stock Split
On
March 20, 2008, the Board of Directors approved an Amendment for a 1:400 reverse stock split. . All references in the financial
statements to the number of shares outstanding, per share amounts, and stock options data of the Company’s common stock
have been restated to reflect the effect of the reverse stock split for all periods presented.
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
Common
Stock
As
of December 31, 2007, 428,226 common shares were issued and outstanding. The holders of common stock, and of shares issuable upon
exercise of any Warrants or Options, are entitled to equal dividends and distributions, per share, with respect to the common
stock when, as and if declared by the Board of Directors from funds legally available therefore. No holder of any shares of common
stock has a pre-emptive right to subscribe for any securities of the Company nor is any common shares subject to redemption or
convertible into other securities of the Company. Upon liquidation, dissolution or winding up of the Company, and after payment
of creditors and preferred stockholders, if any, the assets will be divided prorata on a share-for-share basis among the holders
of the shares of common stock. All shares of common stock now outstanding are fully paid, validly issued and non-assessable. Each
share of common stock is entitled to one vote with respect to the election of any director or any other matter upon which shareholders
are required or permitted to vote. Holders of the Company's common stock do not have cumulative voting rights, so that the holders
of more than 50% of the combined shares voting for the election of directors may elect all of the directors, if they choose to
do so and, in that event, the holders of the remaining shares will not be able to elect any members to the Board of Directors.
During
the year ended December 31, 2007, the Company issued 343,026 restricted common shares of which 302,076 shares were issued to Consultants
for services totaling $877,100 and 40,950 shares were issue to Directors for services totaling $114,660. As of December 31, 2008,
subscriptions payable totals $75,750.
During
the year ended December 31, 2006, the Company issued 300 restricted common shares to Consultants for services totaling $51,623.
Class
B Preferred Stock
The
Company's Articles of Incorporation (Articles") authorize the issuance of 100,000,000 shares of $0.001 par value Class B
Preferred Stock. No shares of Preferred Stock are currently issued and outstanding. Under the Company's Articles, the Board of
Directors has the power, without further action by the holders of the Common Stock, to designate the relative rights and preferences
of the preferred stock, and issue the preferred stock in such one or more series as designated by the Board of Directors. The
designation of rights and preferences could include preferences as to liquidation, redemption and conversion rights, voting rights,
dividends or other preferences, any of which may be dilutive of the interest of the holders of the Common Stock or the Preferred
Stock of any other series. The issuance of Preferred Stock may have the effect of delaying or preventing a change in control of
the Company without further shareholder action and may adversely affect the rights and powers, including voting rights, of the
holders of Common Stock. In certain circumstances, the issuance of preferred stock could depress the market price of the Common
Stock.
Note
14 – Related Party Transactions
During
the year ended December 31, 2009 and 2008 - None
PPJ
Enterprise and Subsidiaries
Notes
to Consolidated Financial Statements
Note
15– Commitments & Contingencies
Leases
liabilities were 2009 and 2008 - $2,230 and $0.00 respectively
Litigation
AMENDED – ALL LITIGATION CASES WERE TRANSFERRED TO MS. BASU AS OF 1/1/2008
Authorized
Shares and Reverse Stock Split
An
amendment to the Registrant’s Articles of Incorporation to increase the authorized shares to 1,500,000,000 shares of common
stock, to reauthorize the par value of $.001 per share of common stock, and to authorize additional 95,000,000 shares of preferred
stock making it a total of 100,000,000 with a par value of $.001 per share of preferred stock that became effective March 20,
2008; and 300,000,000 Free Trading shares also were registered with Nevada Secretary of State on March 20, 2008.
On
March 20, 2008, the Board of Directors approved an Amendment for a 1:400 reverse stock split. . All references in the financial
statements to the number of shares outstanding, per share amounts, and stock options data of the Company’s common stock
have been restated to reflect the effect of the reverse stock split for all periods presented.
Equity